New drug tested to keep critically ill patients comfortably asleep
NCT ID NCT05913336
Summary
This study tested a drug called remimazolam to see if it could safely keep adult ICU patients comfortably sedated while they were on a breathing machine for at least three days. The main goal was to see how well the drug maintained the right level of sleep without needing extra rescue medications. Researchers enrolled 24 patients to monitor the drug's effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION IN THE ICU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550001, China
Conditions
Explore the condition pages connected to this study.